Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (sJIA): TENDER 52-week data

被引：0
|
作者：
Fabrizio De Benedetti
Hermine Brunner
Nicola Ruperto
R Cuttica
Clara Malattia
Rayfel Schneider
Patricia Woo
Despina Eleftheriou
Eileen Baildam
Ruben Burgos-Vargas
Pavla Dolezalova
Stella M Garay
Rik Joos
Nico Wulffraat
Zbyszek Zuber
Francesco Zulian
Carine Wouters
Ricardo M Xavier
Lawrence Zemel
Stephen Wright
Andy Kenwright
Alberto Martini
Daniel Lovell
机构：
[1] Alder Hey Children's Foundation NHS Trust,
[2] Charles University in Prague,undefined
[3] Children St. Louis Hospital,undefined
[4] Cincinnati Children's Hospital Medical Center,undefined
[5] Cincinnati Children's Medical Center,undefined
[6] Connecticut Children's Medical Center,undefined
[7] Great Ormond Street Children Hospital,undefined
[8] Hospital de Clínicas de Porto Alegre,undefined
[9] Hospital for Sick Children,undefined
[10] Hospital General de Niños Pedro de Elizalde,undefined
[11] Hospital General Mexico Univiersidad Nacional Autonoma Mexico,undefined
[12] Hospital IAEP,undefined
[13] La Plata,undefined
[14] Institute of Child Health,undefined
[15] IRCCS G. Gaslini,undefined
[16] IRCCS Ospedale Pediatrico Bambino Gesù,undefined
[17] Roche,undefined
[18] Welwyn,undefined
[19] University Hospital Ghent,undefined
[20] University Hospital Leuven,undefined
[21] University Medical Center Utrecht,undefined
[22] University of Padua,undefined
来源：
Pediatric Rheumatology | / 10卷 / Suppl 1期
关键词：
Juvenile Idiopathic Arthritis; Pneumothorax; Tocilizumab; ACR70 Response; Physician Global Assessment;
D O I：
10.1186/1546-0096-10-S1-A58
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data
    F De Benedetti
    H Brunner
    N Ruperto
    R Schneider
    P Woo
    R Burgos-Vargas
    P Dolezalova
    R Joos
    N Wulffraat
    Z Zuber
    F Zulian
    R Allen
    D Brown
    J Chaitow
    M Pardeo
    G Espada
    B Flato
    V Gerloni
    G Horneff
    S Wright
    A Kenwright
    D Lovell
    A Martini
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [2] Efficacy and safety of tocilizumab in patients with Systemic Juvenile Idiopathic Arthritis (sJIA): 12-week data from the Phase 3 TENDER trial
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Calvo, I.
    Cutica, R.
    Malattia, C.
    Schneider, R.
    Woo, P.
    Wouters, C.
    Xavier, R.
    Zemel, L.
    Wright, S.
    Kenwright, A.
    Lovell, D.
    Martini, A.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 371 - 371
  • [3] EFFICACY AND SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 2-YEAR DATA FROM TENDER, A PHASE 3 CLINICAL TRIAL
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Kenwright, A.
    Devlin, C.
    Calvo, I.
    Cuttica, R.
    Ravelli, A.
    Schneider, R.
    Eleftheriou, D.
    Wouters, C.
    Xavier, R.
    Zemel, L.
    Baildam, E.
    Burgos-Vargas, R.
    Dolezalova, P.
    Garay, S. M.
    Joos, R.
    Grom, A.
    Wulffraat, N.
    Zuber, Z.
    Zulian, F.
    Lovell, D.
    Martini, A.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 425 - 425
  • [4] THE EFFICACY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: 52-WEEK DATA FROM A PHASE 3 CLINICAL TRIAL
    De Benedetti, Fabrizio
    Brunner, Hermine
    Allen, Roger
    Brown, Diane
    Chaitow, Jeffrey
    Pardeo, Manuela
    Espada, Graciela
    Flato, Berit
    Horneff, Gerd
    Devlin, Clare
    Kenwright, Andrew
    Schneider, Rayfel
    Woo, Patricia
    Martini, Alberto
    Lovell, Daniel
    Ruperto, Nicola
    [J]. RHEUMATOLOGY, 2012, 51 : 76 - 76
  • [5] PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF TOCILIZUMAB (TCZ) IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (sJIA).
    Zhang, X.
    Morcos, P. N.
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Schaefer, F.
    Roseti, S.
    Kenwright, A.
    Martini, A.
    Lovell, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S36 - S36
  • [6] Tocilizumab in patients with Systemic Juvenile Idiopathic Arthritis (sJIA): 12-week Pharmacokinetic (PK) and Pharmacodynamic (PD) data from the Phase 3 TENDER Trial
    Ruperto, N.
    Zhang, A.
    Morcos, P. N.
    Huppertz, H.
    Minden, K.
    Myones, B.
    Onel, K.
    Siammopoulou, A.
    Silva, C.
    Kenwright, A.
    Roseti, S.
    De Benedetti, F.
    Lovell, D.
    Martini, A.
    Brunner, H.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 421 - 421
  • [7] Efficacy and Safety of Tocilizumab in Patients with Severe Systemic Juvenile Idiopathic Arthritis
    Alekseeva, Ekaterina I.
    Denisova, Rina V.
    Valieva, Saniya I.
    Bsarova, Tatyana M.
    Isaeva, Kseniya B.
    Chistyakova, Evgeniya G.
    Sleptsova, Tatyana V.
    Mitenko, Elena V.
    [J]. INTERNATIONAL JOURNAL OF BIOMEDICINE, 2011, 1 (04) : 190 - 198
  • [8] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [9] Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
    Horneff G.
    Huppertz I.
    Haas P.
    Minden K.
    Ganser G.
    Hospach A.
    Trauzeddel R.
    [J]. Pediatric Rheumatology, 13 (Suppl 1)
  • [10] SAFETY AND EFFICACY OF SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH SYSTEMIC AND POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
    Ramanan, Athimalaipet V.
    Brunner, Hermine I.
    Ruperto, Nicola
    Martini, Alberto
    Cuttica, Ruben J.
    Weiss, Jennifer E.
    Henrickson, Michael
    Schmeling, Heinrike
    Anton, Jordi
    Minden, Kirsten
    Horneff, Gerd
    Gamir-Gamir, Maria Luz
    Hufnagel, Markus
    Douglass, Wendy
    Wells, Chris
    Wimalasundera, Sunethra
    Mallalieu, Navita L.
    Lovell, Daniel J.
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2019, 58
12345